Bicara Therapeutics Inc. Shares Outstanding (Cover Page)
Bicara Therapeutics Inc. (BCAX) had Shares Outstanding (Cover Page) of 66.17 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 66.17M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 65.70M shares.
- 2026-03-24: Entity Common Stock, Shares Outstanding 65.47M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 54.78M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 66.17M shares 10-Q · filed 2026-08-11 |
| 2026-05-05 | 65.70M shares 10-Q · filed 2026-05-11 |
| 2026-03-24 | 65.47M shares 10-K · filed 2026-03-30 |
| 2025-11-05 | 54.78M shares 10-Q · filed 2025-11-10 |
| 2025-08-06 | 54.56M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 54.54M shares 10-Q · filed 2025-05-13 |
| 2025-03-24 | 54.52M shares 10-K · filed 2025-03-27 |
| 2024-11-08 | 54.42M shares 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |